EzBiome
EzBiome is a US-based microbiome company providing cGMP-compliant microbial identification and precision-taxonomy bioinformatics services to academic researchers, pharmaceutical/biotech firms, and probiotic manufacturers through its EzBioCloud platform and curated reference databases.
- Company typePrivate
- Founded2020
- HeadquartersGaithersburg, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What EzBiome does
EzBiome is a US-based microbiome company founded in 2020 and headquartered in Gaithersburg, Maryland, operating as a subsidiary of CJ Bioscience (formerly ChunLab Inc). It delivers precision taxonomy-based microbial identification and microbiome research services through its EzBioCloud and EzBioCloud Pro cloud platforms, backed by what the company describes as the world's largest curated 16S rRNA reference database (21,529 species and subspecies) and a whole genome database (14,400+ species and subspecies), with >96% species-level identification rates reported for human microbiome samples. Core service lines include 16S/ITS amplicon sequencing, shallow and deep shotgun metagenomics, isolate whole genome sequencing, microbiome taxonomic profiling (MTP), comparative genomics, and the GRIIS probiotic strain certification offering, all executed in a GLP-accredited, cGMP-compliant laboratory. The company also sells custom bioinformatics, biomarker discovery, and collaborative research services leveraging ML and statistical methods on top of its taxonomy stack.
The company monetizes through a mix of annual subscription licenses (e.g., TrueBac ID 16S Professional starting at $500/year, TrueBac ID Genome Basic at $1,000/year, MTP Premium at $3,500 for up to 100 samples), usage-based per-sample fees, quote-based enterprise plans with private servers and API access, and project-based professional services. A freemium layer — free 30-day trials, free public dataset access, and complimentary services for non-profit academic publication work — feeds a sales-led funnel run through direct enterprise field sales, HubSpot-scheduled consultations, and inbound via the EzBioCloud platform. Customer segments span academic research institutions, pharmaceutical and biotech firms, probiotic and dietary supplement manufacturers (the primary segments), plus healthcare/clinical, bio-manufacturing, government, and other microbiome companies as secondary segments, with reported reach across 150+ countries and 55,000+ registered platform users.
EzBiome firmographics
Firmographics- Name
- EzBiome
- Legal name
- EzBiome, Inc.
- Website
- https://ezbiome.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- EzBiome is a US-based microbiome company providing cGMP-compliant microbial identification and precision-taxonomy bioinformatics services to academic researchers, pharmaceutical/biotech firms, and probiotic manufacturers through its EzBioCloud platform and curated reference databases.
- Ownership category
- akta.pro rank
EzBiome industry classification
Industry- Product category
- Microbial Bioinformatics and Sequencing Services
- NAICS
- Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)
- akta.pro secondary industries
- Microbiome & Metagenomics Services (HLAGANAH), Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH)
Keywords
Where EzBiome is headquartered
LocationHeadquarters
- HQ city
- Gaithersburg
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
EzBiome business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- Subscription Licenses: Annual subscription-based licenses for bioinformatics platform access including TrueBac ID (16S and Genome), Microbiome Taxonomic Profiling, Whole Genome analysis, and Comparative Genomics. Licenses have fixed terms with analysis and storage capacity limits.
- Sample-based Analysis Services: Per-sample pricing for microbial identification and microbiome sequencing services. Customers purchase sample credits or analysis packages based on their research needs.
- Enterprise Plans: Custom enterprise pricing for institutions requiring private servers, batch upload capabilities, API access, and multiple user IDs. Includes direct access to sales team for customized quotes.
- GRIIS Premium Services: Premium genome analysis and certification services for probiotic strain authentication, safety assessment, and compositional screening. Includes GRIIS Essential (whole genome analysis) and GRIIS Composition (product composition testing).
- Custom Bioinformatics Services: Collaborative research and custom bioinformatics solutions for specialized microbiome and microbial sequencing projects. PhD-level scientists provide tailored analysis and in silico studies.
- Free Services (Freemium): Free complimentary content including public Human Microbiome and Environmental Microbiome data. Free analysis services available for researchers affiliated with non-profit academic institutions for publications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | TrueBac ID 16S - Trial tier |
| Subscription | Annual | TrueBac ID 16S - Professional |
| Subscription | Annual | TrueBac ID 16S - Premium |
| Subscription | Annual | TrueBac ID Genome - Basic |
| Subscription | Annual | TrueBac ID Genome - Premium |
| Subscription | Annual | Microbiome Taxonomic Profiling - Premium |
| Subscription | Annual | Microbiome Taxonomic Profiling - Enterprise |
| Subscription | Annual | Bundle Discounts |
| Other | Multi-year contract | Custom Services |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
EzBiome product offering
Product offeringCore offering
EzBiome provides cGMP-compliant microbial identification, microbiome sequencing, and bioinformatics analysis services through its EzBioCloud cloud platform. The company offers precision taxonomy-based identification of bacteria and fungi, amplicon and shotgun metagenomic sequencing, whole genome analysis, comparative genomics, and biomarker discovery for microbiome-related therapeutics and diagnostics, backed by the world's largest curated reference databases.
Product overview
EzBiome is a microbiome company offering a comprehensive portfolio of microbial identification and microbiome research solutions through its EzBioCloud and EzBioCloud Pro cloud-based bioinformatics platforms. The product portfolio centers on three core service pillars: (1) Microbial Identification services including EzBac-16SID (16S rRNA-based) and EzBac-GenomeID (whole genome-based) for bacterial identification, plus EzFun-ITSID for fungal identification; (2) Microbiome Sequencing and Analysis including Amplicon Sequencing (16S/ITS), Shallow and Deep Shotgun Sequencing, and Isolate Whole Genome Sequencing, all processed through the MTP (Microbiome Taxonomic Profiling) platform; and (3) Advanced Genomics services including Whole Genome Analysis (WG) and Comparative Genomics (CG). The company also offers specialized GRIIS services (Essential and Composition) for probiotic strain certification, Biomarker Discovery services using proprietary Precision Microbiome Discovery Platform, and Custom Bioinformatics solutions. All services leverage the expert-curated EzBioCloud reference database with >21,000 bacterial species and are performed in cGMP-compliant facilities.
Differentiator
Problem solved
Functional benefit
Brands
- EzBioCloud: Cloud-based bioinformatics platform for taxonomy, ecology, genomics, metagenomics, and microbiome analysis. Includes tools for microbial identification, microbiome taxonomic profiling, whole genome analysis, and comparative genomics.
- TrueBac ID
- GRIIS
Products and services
- EzBioCloud
Quantifiable outcome
- >96% species-level identification rate for human microbiome samples
- +4 more outcomes
Companies that use EzBiome
Customer profileSegments7 records
Ideal customer profiles4 records
EzBiome technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature7 records
EzBiome partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CJ BiosciencecoreCJ Bioscience (formerly ChunLab Inc.) is the parent company of EzBiome. EzBiome is a subsidiary of CJ Bioscience and leverages the parent company's expertise in microbiome research, database development, and bioinformatics. The relationship provides access to extensive prior research including EzTaxon, EzTaxon-e, and EzGenome databases.
Scale indicators12 records
Recent moves6 records
Expansion highlights6 records
EzBiome competitors and assessment
Company assessmentDirect peers
- Diversigen (Bio-Techne): Diversigen provides shotgun metagenomic and 16S sequencing services coupled with bioinformatics analytics for microbiome research, directly competing with EzBiome's microbiome sequencing and EzBioCloud analysis offerings. Acquired by Bio-Techne in 2021, Diversigen operates at meaningfully larger scale in the same academic and pharma customer base.
- CosmosID: CosmosID operates a microbial identification and microbiome analytics platform built on curated reference databases, with services spanning bacterial ID, microbiome profiling, and pathogen detection. The closest direct peer to EzBiome's TrueBac ID and EzBioCloud stack, sharing a database-driven, NGS-based business model and competing for the same pharma and academic customers.
- IDbyDNA (BioMérieux): IDbyDNA offers metagenomics-based pathogen detection and microbial identification for infectious disease diagnostics and clinical research, now part of BioMérieux. Competes with EzBiome's TrueBac ID and EzBioCloud MTP services in the clinical microbiology and infectious-disease research segments.
Broad incumbents
- Zymo Research: Zymo Research supplies DNA extraction kits, sample collection devices, and microbiome analysis services including its BIOMICS service, overlapping with EzBiome across the microbiome workflow. Broader product portfolio and larger organization make it a broad incumbent rather than a direct overlap on the database-analytics stack.
- Qiagen: Qiagen provides sample-preparation technologies and bioinformatics (Ingenuity Pathway Analysis, CLC Genomics Workbench) used by the same microbiome researchers EzBiome serves. A broad incumbent offering integrated wet-lab plus analysis bundles rather than specializing in curated microbiome databases.
- Illumina: Illumina dominates the sequencing-instrument layer that EzBiome's services depend on and offers downstream analytics through BaseSpace Sequence Hub. While not a direct microbial-identification competitor, Illumina's push into integrated sequencing plus analysis bundles creates strategic overlap with EzBiome's combined lab + platform model.
- Eurofins Genomics: Eurofins Genomics operates a global sequencing services business including microbial identification and microbiome services, competing with EzBiome for European and global pharma and academic customers. A broad incumbent with significantly larger operational scale.
- bioMérieux: bioMérieux is a global leader in clinical microbiology diagnostics and through its acquisition of BioFire and IDbyDNA overlaps with EzBiome's TrueBac ID and infectious-disease microbial identification work. Operates at much larger scale across regulatory-grade clinical microbiology.
Others
- DNA Genotek (OraSure Technologies): DNA Genotek supplies microbiome sample collection devices (OMNIgene•GUT, ORAcollect) used by researchers who later send samples to EzBiome for analysis. A complementary ecosystem enabler rather than a competitor, but a key node in the same microbiome research workflow.
Emerging players
- Second Genome (now part of EDX Medical): Second Genome historically combined microbiome discovery services with therapeutic development, overlapping with EzBiome's Precision Taxonomy Discovery Platform and biomarker discovery work. A relevant emerging peer in the microbiome biomarker / pharma collaboration space.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
EzBiome social profiles
Digital presenceEzBiome compliance and trust
Trust signalCompliance4 records
EzBiome financial estimates
Financial estimateRevenue estimate
Valuation estimate
EzBiome leadership team
Management profileNumber of profiles
Profiles1 record
EzBiome funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EzBiome M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EzBiome
What does EzBiome do?
EzBiome provides cGMP-compliant microbial identification, microbiome sequencing, and bioinformatics analysis services through its EzBioCloud cloud platform. The company offers precision taxonomy-based identification of bacteria and fungi, amplicon and shotgun metagenomic sequencing, whole genome analysis, comparative genomics, and biomarker discovery for microbiome-related therapeutics and diagnostics, backed by the world's largest curated reference databases.
Is EzBiome a public or private company?
EzBiome is a private company. It is classified as corporate owned and is currently operating.
When was EzBiome founded?
EzBiome was founded in 2020. It employs 1 to 10 people.
Where is EzBiome based?
EzBiome is headquartered in Gaithersburg, United States, in the North America region.
How does EzBiome make money?
Six revenue lines are on record. Subscription Licenses are the primary driver. The others are sample-based Analysis Services, enterprise Plans, GRIIS Premium Services, custom Bioinformatics Services and free Services (Freemium).
Who are EzBiome's main competitors?
Direct peers on record are Diversigen (Bio-Techne), CosmosID and IDbyDNA (BioMérieux). Broad incumbents are Zymo Research, Qiagen, Illumina, Eurofins Genomics and bioMérieux. DNA Genotek (OraSure Technologies) is listed as an others. Second Genome (now part of EDX Medical) is listed as an emerging player.
Does EzBiome have an API?
Yes. API access is available as part of the Premium plan. The Premium plan includes direct access to the API for bacterial identification services. The Terms of Use explicitly references 'authorized use of the Company API' in the context of prohibited automated scraping activities, indicating a permitted API use case.
What industry is EzBiome in?
EzBiome's product category is Microbial Bioinformatics and Sequencing Services. Its primary akta.pro industry code is HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms, with a secondary code of HLAGANAH, Microbiome & Metagenomics Services. Its NAICS code is 6215 and its SIC code is 8071.